This is a regulatory disclosure submitted to the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) in compliance with SEBI Listing Regulations.
The management of Stallion India Fluorochemicals Limited will be meeting with analysts/investors on Thursday, 26th November, 2026. The specific details of the meeting are as follows:
- Participant: IIFL Capital Asset Management
- Mode: Virtual Meeting
- Time: 2:00 PM IST
The disclosure includes a note that this schedule is subject to change due to exigencies on the part of the Company or the concerned analysts/investors. Any changes to the schedule will be intimated to the Stock Exchanges as required.
It is explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during this meeting.
The letter is signed by Govind Rao, Company Secretary & Compliance Officer (Membership No.: A47094), on behalf of Stallion India Fluorochemicals Limited.